An estimated 112,000 new melanoma cases and 8,500 deaths are expected this year

If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.

Patients with deadly skin cancer could soon benefit from a revolutionary vaccine that has been shown to slash the risk of their disease returning by almost half.

An estimated 112,000 new melanoma cases and 8,500 deaths are expected this year

Un vaccino, combinato all'immunoterapia, ha dimostrato una clamorosa efficacia nell'evitare il rischio di una recidiva di un melanom...

Adjuvant approach will need confirmation from ongoing phase III trial, says expert